Fig. 3From: Effects of intravenous iron on fibroblast growth factor 23 (FGF23) in haemodialysis patients: a randomized controlled trialMedian (interquartile range) levels over the course of the study of serum hepcidin (ng/mL), ferritin (μg/L) and haemoglobin (g/L) in participants treated with iron sucrose (left panels) and ferric carboxymaltose (right panels)Back to article page